These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33850645)

  • 1. Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression.
    Zheng W; Zhou YL; Wang CY; Lan XF; Zhang B; Zhou SM; Yan S; Ning YP
    PeerJ; 2021; 9():e10989. PubMed ID: 33850645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder.
    Zheng W; Gu L; Zhou Y; Wang C; Lan X; Zhang B; Li Z; Ning Y
    Curr Neuropharmacol; 2023; 21(4):1013-1021. PubMed ID: 36173064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression.
    Zheng W; Gu LM; Zhou YL; Wang CY; Lan XF; Zhang B; Shi HS; Wang DF; Ning YP
    Front Psychiatry; 2021; 12():780975. PubMed ID: 34925104
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis.
    Wang M; Zhang B; Zhou Y; Wang C; Zheng W; Liu W; Zhan Y; Lan X; Ning Y
    Pharmacol Rep; 2021 Apr; 73(2):594-603. PubMed ID: 33387333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation.
    Zheng W; Gu LM; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    Front Psychiatry; 2022; 13():855995. PubMed ID: 35546941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
    Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression.
    Zheng W; Zhou YL; Wang CY; Lan XF; Zhang B; Zhou SM; Yan S; Yang MZ; Nie S; Ning YP
    Ther Adv Psychopharmacol; 2021; 11():20451253211014320. PubMed ID: 34035893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression.
    Zheng W; Gu LM; Sun CH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    J Affect Disord; 2022 Mar; 300():109-113. PubMed ID: 34965393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.
    Machado-Vieira R; Yuan P; Brutsche N; DiazGranados N; Luckenbaugh D; Manji HK; Zarate CA
    J Clin Psychiatry; 2009 Dec; 70(12):1662-6. PubMed ID: 19744406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study.
    Kang MJY; Vazquez GH
    J Affect Disord; 2022 Dec; 318():331-337. PubMed ID: 36070831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline insomnia as a predictor of antidepressant efficacy to repeated intravenous ketamine for unipolar and bipolar depression: A preliminary study.
    Liu W; Zhou Y; Wang C; Zheng W; Zhan Y; Lan X; Zhang B; Li H; Chen L; Li M; Ning Y
    J Affect Disord; 2020 Jun; 271():1-8. PubMed ID: 32312692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
    Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
    Luckenbaugh DA; Ibrahim L; Brutsche N; Franco-Chaves J; Mathews D; Marquardt CA; Cassarly C; Zarate CA
    Bipolar Disord; 2012 Dec; 14(8):880-7. PubMed ID: 22978511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation.
    Zheng W; Zhou YL; Wang CY; Lan XF; Zhang B; Zhou SM; Yan S; Yang MZ; Nie S; Ning YP
    Ther Adv Psychopharmacol; 2020; 10():2045125320973794. PubMed ID: 33282177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
    Caliman-Fontes AT; Leal GC; Correia-Melo FS; Paixão CS; Carvalho MS; Jesus-Nunes AP; Vieira F; Magnavita G; Bandeira ID; Mello RP; Beanes G; Silva SS; Echegaray M; Carvalho LP; Machado P; Sampaio AS; Cardoso TA; Kapczinski F; Lacerda ALT; Quarantini LC
    Trends Psychiatry Psychother; 2023; 45():e20210298. PubMed ID: 34904800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.
    Nugent AC; Diazgranados N; Carlson PJ; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Drevets WC; Zarate CA
    Bipolar Disord; 2014 Mar; 16(2):119-28. PubMed ID: 24103187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study.
    Wilkowska A; Włodarczyk A; Gałuszko-Węgielnik M; Wiglusz MS; Cubała WJ
    Neuropsychiatr Dis Treat; 2021; 17():2637-2646. PubMed ID: 34421299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
    Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
    Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.